©The Author(s) 2022.
World J Gastroenterol. Jul 7, 2022; 28(25): 2920-2936
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2920
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2920
Table 5 Comparison of pathogenic mutation sites in preoperative stools vs tumor tissues
| Gene | Positive rate of pathogenic gene mutation sites | |
| Preoperative feces | Tumor tissues | |
| TP53 | 37.04% (10/27) | 46.00% (23/50) |
| APC | 11.11% (3/27) | 18.00% (9/50) |
| KRAS | 25.93% (7/27) | 54.00% (27/50) |
| PIK3CA | 3.70% (1/27) | 22.00% (11/50) |
| FBXW7 | 3.70% (1/27) | 6.00% (3/50) |
| GNAS | 3.70% (1/27) | 4.00% (2/50) |
| PTEN | 3.70% (1/27) | 0 |
| ABL1 | 3.70% (1/27) | 0 |
| PDGFRA | 3.70% (1/27) | 0 |
| ATM | 0 | 2.00% (1/50) |
| SMAD4 | 0 | 2.00% (1/50) |
| BRAF | 0 | 2.00% (1/50) |
| PTPN11 | 0 | 2.00% (1/50) |
| NRAS | 0 | 2.00% (1/50) |
| CTNNB1 | 0 | 2.00% (1/50) |
| VHL | 3.70% (1/27) | 0 |
- Citation: He SY, Li YC, Wang Y, Peng HL, Zhou CL, Zhang CM, Chen SL, Yin JF, Lin M. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis. World J Gastroenterol 2022; 28(25): 2920-2936
- URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2920.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i25.2920